X0609 4 2025-01-27 0 0001433607 InspireMD, Inc. NSPR 0001966214 Gleason Shane Thomas false C/O INSPIREMD, INC. 6303 WATERFORD DISTRICT DRIVE, SUITE 215 MIAMI FL 33126 0 1 0 0 Chief Commercial Officer 0 Common Stock 2025-01-27 4 S 0 3858 2.71 D 1135319 D Common Stock 2025-01-28 4 S 0 2476 2.61 D 1132843 D Common Stock 2025-01-29 4 S 0 3660 2.46 D 1129183 D Common Stock 2025-01-30 4 S 0 2454 2.51 D 1126729 D Common Stock 2025-01-31 4 S 0 9923 2.55 D 1116806 D Common Stock 2025-02-03 4 S 0 7073 2.51 D 1109733 D Common Stock 2025-02-04 4 S 0 5132 2.46 D 1104601 D Common Stock 2025-02-25 4 S 0 10000 3.65 D 1094601 D Common Stock 2025-05-23 4 S 0 2482 2.51 D 1092119 D Common Stock 2025-05-27 4 S 0 1572 2.51 D 1090547 D Common Stock 2025-05-29 4 S 0 3760 2.51 D 1086787 D Common Stock 2025-05-30 4 S 0 7186 2.51 D 1079601 D Common Stock 2026-02-02 4 S 0 2941 1.59 D 1076660 D Common Stock 2026-05-19 4 S 0 22778 1.01 D 1053882 D The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.00 to $1.04. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. /s/ Michael Lawless, Attorney-in-Fact for Shane Gleason 2026-05-21